Geoffrey Beran Rose sold $9,926 of LUNG
CHIEF COMMERCIAL OFFICER at Pulmonx Corp. 6,322 shares at an average of $1.57, traded Dec 1, 2025, filed Dec 3, 2025.
Score components
- +15RoleOfficer
- 0Trade size$10k at market
- 0Share of holdings soldSold 1.7% of holdings
- +15Cluster4 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001804146-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 1, 2025 | SOpen-market sale Common Stock | -683 | $1.57 | $1,072 | 379,105 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stock | -1,738 | $1.57 | $2,729 | 377,367 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stock | -1,522 | $1.57 | $2,390 | 375,845 | Dec 3, 2025 |
| Dec 1, 2025 | SOpen-market sale Common Stock | -2,379 | $1.57 | $3,735 | 373,466 | Dec 3, 2025 |
Related signals
Other insiders at Pulmonx Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | Pulmonx Corp | Glendon E. French III President and CEO | $95k 41,882 shares | -4% | |
| 35Weak | Pulmonx Corp | David Aaron Lehman General Counsel | $32k 14,334 shares | -4% | |
| 30Weak | Pulmonx Corp | Geoffrey Beran Rose Chief Commercial Officer | $18k 7,879 shares | -2% | |
| 35Weak | Pulmonx Corp | Srikanth Radhakrishnan Chief Science & Techn. Officer | $32k 14,245 shares | -4% | |
| 43Moderate | Pulmonx Corp | Glendon E. French III President and CEO | $97k 67,813 shares | -5% | |
| 23Weak | Pulmonx Corp | David Aaron Lehman GENERAL COUNSEL | $17k 12,237 shares | -5% | |
| 21Weak | Pulmonx Corp | Daniel P Florin director | $46k 23,321 shares | -20% | |
| 40Moderate | Pulmonx Corp | Glendon E. French III President and CEO | $14k 8,805 shares | -3% | |
| 30Weak | Pulmonx Corp | David Aaron Lehman GENERAL COUNSEL | $16k 10,278 shares | -4% | |
| 37Weak | Pulmonx Corp | Mehul Joshi Chief Financial Officer & PAO | $13k 7,936 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.